Amreen Husain, MD
Amreen Husain, MD
Medical DIrector
Genentech, Inc.
Division of Gynecologic Oncology
1 DNA Way
South San Francisco,
CA
USA
94080
Papers:
137 - Scientific Plenary
Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer